Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
Current Portion of Long-Term Debt
Clinuvel Pharmaceuticals Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Current Portion of Long-Term Debt
AU$355.8k
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immutep Ltd
ASX:IMM
|
Current Portion of Long-Term Debt
AU$210.1k
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mesoblast Ltd
ASX:MSB
|
Current Portion of Long-Term Debt
$11.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Current Portion of Long-Term Debt
$1.4B
|
CAGR 3-Years
47%
|
CAGR 5-Years
21%
|
CAGR 10-Years
70%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Current Portion of Long-Term Debt
AU$1.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Current Portion of Long-Term Debt
AU$324.4k
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
355.8k
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt amounts to 355.8k AUD.
What is Clinuvel Pharmaceuticals Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
14%
Over the last year, the Current Portion of Long-Term Debt growth was 10%. The average annual Current Portion of Long-Term Debt growth rates for Clinuvel Pharmaceuticals Ltd have been 14% over the past three years .